[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368550-105":59,"doc-detail-368550-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mir-216-is-a-key-regulator-and-potential-marker-in-human-cancers","miR-216 Is a Key Regulator and Potential Marker in Human Cancers","","MicroRNAs, a class of small noncoding RNAs, have been identified as promising biomarkers for cancer identification and management by regulating gene expression and other cellular biological pathways. This review gathers findings for understanding the molecular basis and clinical importance of microRNA-216 (miR-216) in several cancers. Increased or decreased expression of miR-216 has been observed across multiple cancer types, suggesting its activity as an oncogene or tumor suppressor and supporting its potential role in prognosis and early detection, progression, and metastasis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mir-216-is-a-key-regulator-and-potential-marker-in-human-cancers/368550/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mir-216-is-a-key-regulator-and-potential-marker-in-human-cancers/368550.png","ImageObject",300,407,{"name":92,"@type":93},"Sarah ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does miR-216 play in cancers according to the review?","Question",{"text":112,"@type":113},"The review reports that miR-216 expression can be increased or decreased in various cancers, indicating potential oncogenic or tumor-suppressor activity. It is also proposed as a candidate prognostic marker and for early detection.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which cancers are mentioned as showing altered miR-216 expression?",{"text":117,"@type":113},"The abstract lists esophageal cancer, breast cancer, colorectal cancer, gastric cancer, pancreatic cancer, cervical cancer, brain tumor (glioma), prostate cancer, and acute myeloid leukemia. Additional sections mention glioma, breast cancer, bone metastasis, cervical cancer, esophageal cancer, gastric cancer, pancreatic cancer, and colorectal cancer.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is miR-216 considered relevant as a biomarker?",{"text":121,"@type":113},"Because microRNAs regulate gene expression and related cellular pathways, changes in miR-216 levels across tumor types may reflect mechanisms driving tumor development and progression. The review suggests miR-216 could support prognosis and detection of tumor development, progression, and metastasis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368550,1790539231,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962085320529,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","| Review Article |\n| --- |\n|  |\n\nmiR‑216 Is a Key Regulator and Potential Marker in Human  \nCancers  \nMozhgan Mondeali1, Fatemeh Mozaffari2, Pooran Ghiasizadeh3, Sanaz Bakhti4, Marjan Salehi5, Navid Kamali6, Milad Rafat7  \n1Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran, 2Student Research Committee, Arak University of Medical Sciences, Arak, Iran, 3Hygirne Center of Arak, Arak University of Medical Sciences, Arak, Iran, 4Department of Biological Sciences, Islamic Azad University, North Tehran, Tehran, Iran, 5Department of Microbiology, Islamic Azad University, Qom Branch, Qom, Iran, 6Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran, 7Department of Medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran  \nAbstract  \nMicroRNAs, a class of small noncoding RNAs, have been identified as promising biomarkers for cancer identification and management by regulating gene expression and other cellular biological pathways. This review gathers findings for understanding the molecular basis and clinical importance of microRNA‑216 (miR‑216) in several cancers. Increased or decreased expression of miR‑216 has been observed ina variety of cancers, including esophageal cancer, breast cancer, colorectal cancer, gastric cancer, pancreatic cancer, cervical cancer, brain tumor (glioma), prostate cancer, and acute myeloid leukemia, indicating its activity as an oncogene or tumor suppressor. Through this study, we proposed that miR‑216 can potentially be a candidate as a prognostic marker for early detection of tumor development, progression, as well as metastasis in cancer patients.  \nKeywords: Biomarker, cancer, miR‑216, microRNA, microRNA‑216  \nAddress for correspondence: Dr. Milad Rafat, Department of Medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.  \nE‑[mail: miladrafat@yahoo.com](mail: miladrafat@yahoo.com)  \nSubmitted: 26‑May‑2023; Revised: 28‑Dec‑2023; Accepted: 30‑Dec‑2023; Published: 31‑May‑2025  \nIntroductIon  \nThere are about 20,000 protein‑coding genes that constitute about 2% of the human genome. At least 70% of the sequences are transcribed into RNAs, and most of the transcripts have been identified as noncoding RNAs (ncRNAs) .[1‑5] The long ncRNAs with >200 nucleotides and short ncRNAs with 20 nucleotides are recognized as the fundamental regulators of the human genome based on remarkable advances in sequencing techniques and large‑scale genome sequencing.[6‑8] The human genome encodes about 1000 kinds of microRNAs (miRNAs), which are endogenous, noncoding, single‑stranded molecules and have a regulatory role across the mammalian genome. They are present in eukaryotes, and their length ranges from 22 to 24 nucleotides. [9] MiRNAs are responsible for post‑transcription regulations by interacting with messenger RNA (mRNA) and silencing the related gene. They are  \n\n| Access this article online |  |\n| --- | --- |\n| Quick Response Code:\u003Cbr>| Website:\u003Cbr>[www.advbiores.net](www.advbiores.net) |\n|  | DOI:\u003Cbr>10.4103/abr.abr_ 184_23 |\n\nmostly produced by the transcription of other genes’ intron regions via RNA polymerase II.[10] More studies are needed to discover new biological phenomena related to carcinogenesis, like miRNAs. MiRNA expression varies depending on different cancerous tissues and can be raised, lowered, or stay the same.[11] MicroRNA 216 (MiR‑216) containing two homologous miRNAs on chromosome 2p16.1 of the human is more proper as a possible biomarker for cancer prognosis and diagnosis than a therapeutic target. Using the RNAfold (Rfold) webserver ([http://rna.tbi.univie.ac.at/cgi](http://rna.tbi.univie.ac.at/cgi)‑bin/RNAWebSuite/ RNAfold.cgi), the anticipated secondary structure of miR‑216 with a minimum free energy (MFE) of −40.30 kcal/mol and dot‑bracket notation has been shown [Figure 1] .  \nMiR‑216 offlies, mice, humans, and other species w","cbCailPgIG2j0rdn","https://ap.wps.com/l/cbCailPgIG2j0rdn","pdf",476670,"English","# Abstract\n# IntroductIon\n## MicroRNAs and microRNA-216 basics\n# Changes miR-216 in Different Tumors\n## Brain Cancer (Glioma)","[{\"question\":\"What role does miR-216 play in cancers according to the review?\",\"answer\":\"The review reports that miR-216 expression can be increased or decreased in various cancers, indicating potential oncogenic or tumor-suppressor activity. It is also proposed as a candidate prognostic marker and for early detection.\"},{\"question\":\"Which cancers are mentioned as showing altered miR-216 expression?\",\"answer\":\"The abstract lists esophageal cancer, breast cancer, colorectal cancer, gastric cancer, pancreatic cancer, cervical cancer, brain tumor (glioma), prostate cancer, and acute myeloid leukemia. Additional sections mention glioma, breast cancer, bone metastasis, cervical cancer, esophageal cancer, gastric cancer, pancreatic cancer, and colorectal cancer.\"},{\"question\":\"Why is miR-216 considered relevant as a biomarker?\",\"answer\":\"Because microRNAs regulate gene expression and related cellular pathways, changes in miR-216 levels across tumor types may reflect mechanisms driving tumor development and progression. The review suggests miR-216 could support prognosis and detection of tumor development, progression, and metastasis.\"}]","miR-216 Is a Key Regulator and Potential Marker in Human Cancers | PDF",1790177461,18,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/94f8b0491da3e6f22f15be183ce75ef9.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/100660d9ad933c9a536a316929925c8d.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7cadbed69b19ac796946a06391fefadd.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b3dc67dc516e69591a841f9ebcfe2828.webp",980,1268]